Pharmacology of platelet-suppressive agents.
D000244:Adenosine Diphosphate / Q000378:metabolism; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001095:Arachidonic Acids / Q000378:metabolism; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D002994:Clofibrate / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D011464:Epoprostenol / Q000494:pharmacology; D006218:Halofenate / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology; D011465:Prostaglandins, Synthetic / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D001095:Arachidonic Acids; D007093:Imidazoles; D011458:Prostaglandins E; D011465:Prostaglandins, Synthetic; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D006493:Heparin; D011464:Epoprostenol; D002994:Clofibrate; D006218:Halofenate; D001241:Aspirin; D002118:Calcium